Skip to main content
HR 5497 116th Congress House Health Civil actions and liability Drug safety, medical device, and laboratory regulation Health care coverage and access Health information and medical records Marketing and advertising Medical research

Conditional Approval Act

Introduced: December 19, 2019 Introduced by: Westerman, Bruce Republican · Arkansas See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 20, 2019
Referred to the Subcommittee on Health.
Dec 19, 2019
Referred to the House Committee on Energy and Commerce.
Dec 19, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Conditional Approval Act

This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.
What's happening now December 20, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2